Medicare claims analysis

Article

The rise in biopsy-related skin procedures appears medically justified, although further research is needed, according to a recent analysis of Medicare claims data.

Related Videos
Related Content

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Get Ready to Test Your Atopic Dermatitis Knowledge

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Issues Complete Response Letter for Lebrikizumab

October 2nd 2023

Eczema Resources for Your Patients: Week 1

October 2nd 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Get Ready to Test Your Atopic Dermatitis Knowledge

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Issues Complete Response Letter for Lebrikizumab

October 2nd 2023

Eczema Resources for Your Patients: Week 1

October 2nd 2023

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Get Ready to Test Your Atopic Dermatitis Knowledge

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Issues Complete Response Letter for Lebrikizumab

October 2nd 2023

Eczema Resources for Your Patients: Week 1

October 2nd 2023
© 2023 MJH Life Sciences

All rights reserved.